A phase 1 clinical trial has brought new hope for patients with B-cell lymphoma, a type of blood cancer, through an innovative cell-based immunotherapy. Researchers from Washington University School of Medicine in St. Louis, along with other collaborators, have explored the safety and potential
The transformative impact of rapid in-house next-generation sequencing (NGS) technology on cancer treatment is becoming increasingly evident. This advancement is particularly significant in enabling personalized medicine and improving patient outcomes. With the progress in molecular testing and the
Glioblastoma multiforme, an aggressive form of brain cancer, has long been a formidable challenge in the medical field. With patient survival rates stagnating around 15 to 18 months, the need for innovative treatment approaches is critical. NeOnc Technologies, under the leadership of Dr. Thomas
Prostate cancer remains one of the most common cancers among men, and while hormone therapies have significantly improved patient outcomes, resistance to these treatments is a major challenge. The emergence of NXP800, a novel drug currently under clinical trials, offers a promising new approach to
The landscape of cancer therapy is undergoing a transformative shift with the advent of in vivo CAR-T cell therapies. These innovative treatments promise to simplify, accelerate, and reduce the costs of cancer care, marking a significant departure from traditional ex vivo methods. This article
Precision oncology is revolutionizing cancer treatment by tailoring medical care based on the genetic makeup of a patient's tumor. However, significant disparities exist in the effectiveness and availability of these treatments among patients of different ancestries. This article delves into the
